IRX3 and obesity disorder: Using the aP2-CRE for adipose-specific IRX3 inhibition, they show that at the organismal level, adipose specific IRX3 knockdown in mice resulted in 57% reduced fat mass ratio and high-fat-diet induced obesity resistance.